Puma Biotechnology reported $7.74M in Stock for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Agios Pharmaceuticals AGIO:US $ 16.19M 1.49M
Alnylam Pharmaceuticals ALNY:US $ 91.04M 1.26M
Amgen AMGN:US $ 4017M 124M
Array Technologies Inc ARRY:US 124.7M 6.25M
Biogen BIIB:US $ 1254.8M 83M
Biomarin Pharmaceutical BMRN:US $ 713.93M 15.38M
Clovis Oncology CLVS:US $ 22.17M 8.55M
Daiichi Sankyo 4568:JP Y 200860M 16965M
Esperion Therapeutics ESPR:US $ 20.03M 3.89M
Gilead Sciences GILD:US $ 2996M 1313M
Moderna Inc MRNA:US 494M 447.47M
Novartis NOVN:VX SF 6997M 134M
Ptc Therapeutics PTCT:US $ 16.23M 2.46M
Puma Biotechnology PBYI:US $ 7.74M 4.29M
Regeneron Pharmaceuticals REGN:US $ 2164.7M 679M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 12.46M 0.59M
Vertex Pharmaceuticals VRTX:US $ 298.86M 18.09M